INDBInternet News Database 2.5 Updated 2 min ago · 315 sources Show or hide images Light or dark

Long-Acting HIV Treatment Failure Can Limit Future Options

Save Like Comments Compare coverage

Summary

Although virologic failure is uncommon with long-acting injectable HIV treatment, resistance can compromise future treatment options, particularly with dolutegravir and bictegravir.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Long-Acting HIV Treatment Failure Can Limit Future Options

    Although virologic failure is uncommon with long-acting injectable HIV treatment, resistance can compromise future treatment options, particularly with dolutegravir and bictegravir.

Comments

Comments need JavaScript.